Browse by author
Lookup NU author(s): Dr Graham Dark
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
The management of mesothelioma requires a multidisciplinary and multimodality approach to therapy; Chemotherapy offers an improvement in symptoms and quality of life; Patients with poor performance status require careful assessment; Age should not be a factor when deciding treatment; Much of the research from clinical studies to date is heterogeneous and many of the trials underpowered to detect small differences; Symptomatic benefit from anticancer treatment of mesothelioma is comparable with that of other tumours.
Author(s): Dark G
Publication type: Review
Publication status: Published
Journal: Clinical Medicine
Print publication date: 01/07/2003
ISSN (print): 1470-2118
ISSN (electronic): 1473-4893
PubMed id: 12938743